Blood sample study for lung disease patients
Part of Immune system & allergy, Infections, Lungs & breathing clinical trials.
This study looks at how certain blood cells react in people with lung conditions like asthma, COPD, pneumonia, or COVID-19. By analyzing a blood sample, researchers hope to learn more about the immune system's role in these diseases, which could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a lung condition such as asthma, COPD, pneumonia, tuberculosis, or a viral lung infection like COVID-19 or the flu.
- You must be able to give consent and have a blood sample taken (about 3 tablespoons).
- You must not have cancer or be on cancer treatment, and you must not be taking immunosuppressive drugs.
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
This study compares the lungs of people with airway disease to healthy volunteers to understand inflammation and lung function. You may be eligible if you have airway disease or are a healthy adult.
This study examines how certain white blood cells behave in people with lung cancer or COPD. It aims to better understand the immune response, which could help develop new treatments.
This study looks at how the body’s “innate” (first-line) immune system works in people with COPD compared with healthy volunteers. It may help researchers understand COPD inflammation and how immune responses could be targeted in the future.
This study looks at how lung disease changes a type of blood cell called white blood cells. It may help researchers understand what’s happening in the lungs and how to better monitor or treat lung problems.
This Phase 1/2 study uses detailed “single-cell” testing (from lung samples) to better understand why lung inflammation happens after cancer radiation or immunotherapy. It aims to help choose the right treatment approach for people with radiation pneumonitis or immune checkpoint inhibitor pneumonitis.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.